Advertisement

Is vitamin D deficiency predictor of complications development in patients with HCV-related cirrhosis?

  • Anna LicataEmail author
  • Maria Giovanna Minissale
  • Filippo A. Montalto
  • Maurizio Soresi
IM - COMMENTARY

Around 130–170 million people in the world, according to WHO estimates, are infected with hepatitis C virus (HCV), with a wide variability in geographical distribution [1]. HCV causes both acute and chronic hepatitis, the latter evolving to cirrhosis with impairment of liver structure and function, development of fibrosis, portal hypertension and hyperdinamic circulation [2]. During this progression, the varying degree of fibrosis can be assessed through non-invasive serological tests and/or imaging techniques, which have been proposed as reliable indicators [3]. Clinical complications of cirrhosis are esophageal varices, ascites with spontaneous bacterial peritonitis, hepato-renal syndrome, hepato-pulmunary syndrome and hepatic encephalopathy [4, 5].

Vitamin D is a secosteroid hormone which is involved in several processes [6]. It has pleiotropic effects being mainly implicated in bone and calcium homeostasis, cardiovascular system function, pancreatic endocrine cells, muscle and...

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Statement of human and animal rights

As Commentary this article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
  2. 2.
    Licata A, Mazzola A, Ingrassia D et al (2014) Clinical implications of the hyperdynamic syndrome in cirrhosis. Eur J Intern Med 25:795–802CrossRefGoogle Scholar
  3. 3.
    Soresi M, Giannitrapani L, Cervello M et al (2014) Non invasive tools for the diagnosis of liver cirrhosis. World J Gastroenterol 20:18131–18135CrossRefGoogle Scholar
  4. 4.
    Moller S, Bendtsen F (2015) Complication of cirrhosis. A 50 years flashback. Scand J Gastroenterol 50:763–780Google Scholar
  5. 5.
    Poordad FF (2015) Presentation and complications associated with cirrhosis of the liver. Curr Med Res Opin 31:925–937CrossRefGoogle Scholar
  6. 6.
    Perez-Lopez FR (2007) Vitamin D: the secosteroid hormone and human reproduction. Gynecol Endocrinol 23:13–24CrossRefGoogle Scholar
  7. 7.
    Caprio M, Infante M, Calanchini M et al (2016) Vitamin D: not just bone. Evidence for pleiotropic extraskeletal effects. Eat Weight Disord 22:27–41CrossRefGoogle Scholar
  8. 8.
    Hewison M (2011) Antibacterial effects of vitamin D. Nat Rev Endocrinol 7:337–345CrossRefGoogle Scholar
  9. 9.
    Mangin M, Sinha R, Fincher K (2014) Inflammation and vitamin D: the infection connection. Inflamm Res 63:803–819CrossRefGoogle Scholar
  10. 10.
    Lin R (2016) Crosstalk between vitamin D metabolism, VDR signaling and innate immunity. BioMed Res IntGoogle Scholar
  11. 11.
    Gombart AF (2009) The vitamin D-antimicrobial pathway and its role against infection. Future Microbiol 4:1151–1165CrossRefGoogle Scholar
  12. 12.
    Macaluso FS, Maida M, Minissale MG, et al (2013) Metabolic factors and chronic hepatitis C: a complex interplay. Bio Med Research International, pp 564–645Google Scholar
  13. 13.
    Petta S, Grimaudo S, Tripodo C et al (2014) The hepatic expression of vitamin D receptor is inversely associated with the severity of liver damage in genotype 1 chronic hepatitis C patients. J Clin Endocrinol Metab 100:193–200CrossRefGoogle Scholar
  14. 14.
    Hariri Mitra, Zohdi Sara (2019) Effect of vitamin D on non-alcoholic fatty liver disease: a systematic review of randomized controlled clinical trials. Int J Prev Med 10:14Google Scholar
  15. 15.
    Hoe E, Nathanielz J, Toh ZQ, Spry L, Marimia R, Balloch A et al (2016) Anti-inflammatory effects of vitamin D on human immune cells in the context of bacterial infection. Nutrients 8:806CrossRefGoogle Scholar
  16. 16.
    Holick MF (2007) Vitamin D deficiency. N Engl J Med 57:266–281CrossRefGoogle Scholar
  17. 17.
    Arteh J, Narra S, Nair S (2010) Prevalence of vitamin D deficiency in chronic liver disease. Dig Dis Sci 55:2624–2628CrossRefGoogle Scholar
  18. 18.
    Yousif MM, Sadek AMEM, Farrag HA, Selim FO, Hamed EF, Salama RI (2019) Associated vitamin D deficiency is a risk factor for the complication of HCV-related liver cirrhosis including hepatic encephalopathy and spontaneous bacterial peritonitis. Intern Emerg Med.  https://doi.org/10.1007/s11739-019-02042-2 Google Scholar
  19. 19.
    Gaksch M, Jorde R, Grimnes G et al (2017) Vitamin D and mortality: individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium. PLoS One 12(2):e0170791.  https://doi.org/10.1371/journal.pone.0170791 CrossRefGoogle Scholar
  20. 20.
    Buonomo AR, Zappulo E, Scotto R et al (2017) Vitamin D deficiency is a risk factor for infections in patients affected by HCV related liver cirrhosis. Int J Infect Dis 63:23–29CrossRefGoogle Scholar
  21. 21.
    Buonomo AR, Scotto R, Zappulo E, Nerilli M, Pinchera B, Perruolo G, Formisano P, Nappa S, Gentile I (2019) Severe vitamin D deficiency increases mortality among patients with liver cirrhosis regardless of the presence of HCC. In Vivo 33(1):177–182.  https://doi.org/10.21873/invivo.11456 CrossRefGoogle Scholar
  22. 22.
    Anty R, Tonohouan M, Ferrari-Panaia P et al (2014) Low levels of 25-hydroxy vitamin D are independently associated with the risk of bacterial infection. Clin Transl Gastroenterol 5:e56CrossRefGoogle Scholar
  23. 23.
    Trepo E, Ouziel R, Pradat P et al (2013) Marked 25-hydroxyvitaminD deficiency is associated with poor prognosis inpatients with alcoholic liver disease. J Hepatol 59:344–350CrossRefGoogle Scholar
  24. 24.
    Vandamme D, Landuyt B, Luyten W et al (2012) A comprehensive summary of LL37, the factotum human cathelicidin peptide. Cell Immunol 280:22–35CrossRefGoogle Scholar
  25. 25.
    Zhang C, Zhao L, Ding Y et al (2016) Enhanced LL-37 expression following vitamin D supplementation in patients with cirrhosis and spontaneous bacterial peritonitis. Liver Int 36:68–75CrossRefGoogle Scholar
  26. 26.
    Pelajo CF, Lopez Benitez JM, Miller LC (2010) Vitamin D and autoimmune rheumatological disorders. Autoimmun Rev 9:507–510CrossRefGoogle Scholar
  27. 27.
    Li J, Chen N, Wang D et al (2018) Efficacy of vitamin D in treatment of inflammatory bowel disease. A meta-analysis. Medicine (Baltimore) 97:12662CrossRefGoogle Scholar
  28. 28.
    Hye J, Kim JW, Lee KJ (2019) Vitamin D deficiency predicts severe acute pancreatitis. UEG J 7:90–95Google Scholar
  29. 29.
    Vidot H, Potter A, Cheng R, Allman-Farinelli M, Shackel N (2017) Serum 25-hydroxyvitamin D deficiency and hepatic encephalopathy in chronic liver disease. World J Hepatol 9:510–518CrossRefGoogle Scholar
  30. 30.
    Mayne PE, Burne THJ (2019) Vitamin D in synaptic plasticity, cognitive function, and neuropsychiatric illness. Trends Neurosci S0166-2236(19)30006-2.  https://doi.org/10.1016/j.tins.2019.01.003 Google Scholar
  31. 31.
    Annweiler C, Allali G, Allain P et al (2009) Vitamin D and cognitive performance in adults: a systematic review. Eur J Neurol 16:1083–1089CrossRefGoogle Scholar

Copyright information

© Società Italiana di Medicina Interna (SIMI) 2019

Authors and Affiliations

  1. 1.Medicina Interna ed Epatologia, Dipartimento di Promozione della Salute, Materno-infantile, di Medicina Interna e Specialistica di Eccellenza “G. D’Alessandro”, PROMISEUniversità di PalermoPalermoItaly

Personalised recommendations